Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Pr...

FDA Recall #D-0511-2024 — Class I — April 20, 2024

Recall #D-0511-2024 Date: April 20, 2024 Classification: Class I Status: Ongoing

Product Description

Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77018, internally assigned NDC 99000-9278-64

Reason for Recall

Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate

Recalling Firm

Revive Rx LLC dba Revive Rx Pharmacy — Houston, TX

Classification

Class I — Reasonable probability of serious adverse health consequences or death.

Product Type

Drugs

Product Quantity

751 vials

Distribution

USA Nationwide

Code Information

Lot #: 748127, Exp 9/24/2024

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated